TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 72 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2014. The put-call ratio across all filers is 0.38 and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $126 | +5.9% | 2,977 | +4.7% | 0.00% | – |
Q4 2023 | $119 | +7.2% | 2,844 | -3.1% | 0.00% | – |
Q3 2023 | $111 | +6.7% | 2,934 | +6.8% | 0.00% | – |
Q2 2023 | $104 | +55.2% | 2,747 | -0.7% | 0.00% | – |
Q1 2023 | $67 | -17.3% | 2,766 | -1.4% | 0.00% | – |
Q4 2022 | $81 | -99.9% | 2,805 | -0.4% | 0.00% | – |
Q3 2022 | $84,000 | -16.8% | 2,815 | +0.3% | 0.00% | – |
Q2 2022 | $101,000 | -20.5% | 2,806 | -4.5% | 0.00% | – |
Q1 2022 | $127,000 | -13.0% | 2,938 | +0.5% | 0.00% | – |
Q4 2021 | $146,000 | -26.6% | 2,922 | -6.7% | 0.00% | -100.0% |
Q3 2021 | $199,000 | -17.8% | 3,133 | -6.8% | 0.00% | 0.0% |
Q2 2021 | $242,000 | -1.6% | 3,360 | +0.8% | 0.00% | 0.0% |
Q1 2021 | $246,000 | -58.9% | 3,332 | -22.0% | 0.00% | -66.7% |
Q2 2014 | $599,000 | +25.8% | 4,270 | -0.4% | 0.00% | +50.0% |
Q1 2014 | $476,000 | +41.7% | 4,287 | +26.2% | 0.00% | 0.0% |
Q4 2013 | $336,000 | – | 3,397 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Claret Asset Management Corp | 94,031 | $10,164,000 | 2.02% |
ALTERNA WEALTH MANAGEMENT, INC | 20,530 | $2,219,000 | 1.88% |
Strategic Global Advisors, LLC | 72,308 | $7,816,000 | 1.64% |
Analyst IMS Investment Management Services Ltd. | 28,438 | $3,074,000 | 0.95% |
Freestone Capital Holdings, LLC | 129,757 | $14,025,000 | 0.83% |
Hudson Capital Management LLC | 12,394 | $1,339,667,000 | 0.82% |
FORT, L.P. | 19,158 | $2,071,000 | 0.42% |
MENTA CAPITAL LLC | 6,880 | $744,000 | 0.32% |
Empirical Finance, LLC | 9,511 | $1,028,000 | 0.26% |
ALGERT GLOBAL LLC | 4,071 | $440,000 | 0.25% |